Monday, November 19, 2018

Examining Cost and Benefit: Quality Care in Cancer is Not Only a Matter of Proper Medication

The European Society of Medical Oncology, ESMO, the leading professional organization for medical oncology with over 18,000 members representing oncology professionals from over 150 countries worldwide, this week, shared concerns expressed in a scientific paper discussing the rising costs of cancer medicines. The purpose of the study was to determine if clinical benefits of novel anticancer drugs, measured by the...

Fewer Infections and Less Clotting Associated with Neutral Fluid Displacement Connector

The design of intravenous needleless connectors or NCs plays a substantial role in development of the potentially deadly hospital acquired-catheter related blood stream infection (HA-CRBSI) and the associated risk. Research on different types of needleless IV connectors led a Johns Hopkins cancer center to pilot a new "neutral pressure" IV connector. The results were presented at the at the...

Related articles